Class & Mechanism
AICAR, or 5-Aminoimidazole-4-carboxamide ribonucleotide, is a nucleotide that acts as an activator of AMP-activated protein kinase (AMPK). AMPK is a key energy-sensing enzyme that plays a central role in regulating cellular metabolism, particularly under conditions of energy stress. By activating AMPK, AICAR promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis, while inhibiting anabolic processes such as lipogenesis and glycogenesis [9].
Research-documented benefits
Local corpus: silent.
General-knowledge benefits
AICAR has been studied for its potential metabolic benefits, particularly in the context of diabetes, obesity, and metabolic syndrome. Activation of AMPK by AICAR has been shown to improve insulin sensitivity, promote fatty acid oxidation, and increase glucose uptake in preclinical models [9]. Additionally, AICAR has been investigated for its potential to modulate inflammation, support endothelial function, and promote neuroprotection [9].
Typical injectable protocol
The typical injectable protocol for AICAR is not well-established in the literature. However, based on its use in preclinical studies, it is generally administered subcutaneously (SC) or intravenously (IV) in the range of milligrams (mg) per dose, with treatment cycles varying depending on the specific metabolic condition being treated and the individual's response to therapy.
Key risks / contraindications
As with any nucleotide therapy, AICAR carries a risk of allergic reactions or anaphylaxis. It should not be used in patients with a known hypersensitivity to the compound or any of its components. Additionally, its safety in pregnant or breastfeeding women is not well-established.
Bottom line
AICAR is an AMPK activator with potential therapeutic benefits in modulating metabolism and improving insulin sensitivity. Its use is primarily investigational, and further research is needed to fully understand its mechanisms and establish its safety and efficacy profile.
References
- Adenoviruses_ Basic Biology to Gene Therapy
- Advances in drug delivery
- Antioxidants and redox signaling_ impact on NF-κB and Nrf2
- Antisense Research and Application
- Antisense oligonucleotides_ the state of the art
- Biomaterials Science_ An Introduction to Materials in Medicine
- Cancer_ Principles & Practice of Oncology
- Cells, Aging, and Human Disease
- Chemical Biology of Nucleic Acids
- Gene Therapy_ Therapeutic Mechanisms and Strategies
- Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
- Inclisiran in patients at high cardiovascular risk
- Medicinal Chemistry of Anticancer Drugs
- Mitochondrial Medicine_ Volume II, Manipulating Mitochondrial Function
- Oxidative Stress and Inflammation in Non-communicable Diseases_ Molecular Mechanisms and Perspectives in Therapeutics
- Peptide Bioregulators in Gerontology
- Peptide Therapeutics_ Design and Development
- Peptides and Non Peptides of Oncologic and Endocrine Interest
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Principles and Practice of the Biologic Therapy of Cancer
- Prodrugs_ Challenges and Rewards
- RNA Interference Technology
- RNA Interference_ From Biology to Clinical Applications
- RNA Therapeutics_ Function, Design, and Delivery
- Sirtuins and NAD br sup + sup br
- The Metabolic Role of Phosphate